Skip to content
Search

Latest Stories

Pharmacy innovation in practice

This innovative pharmacy-clinic model could be a glimpse into the future of pharmacy
LIPS Pharmacy Battersea

LIPS Pharmacy Battersea: This innovative pharmacy-clinic model could be a glimpse into the future of pharmacy…

Most pharmacies understand that funding from the NHS contract does not cover their overheads and probably never will again. Hence pharmacy owners are increasingly developing a hybrid model with income streams based on over-the-counter ranges and private services.

A few have gone a step further and have a model which is totally based on private services funded by patients, companies and insurance delivered from premises that look very different to an average UK pharmacy. They utilise technology and have a skill-mix that reflects and supports this model with Independent Prescriber Pharmacists and Pharmacy Technicians delivering the services.


One such model is a pharmacy that opened in May 2024 on the top floor of Battersea Power Station – LIPS Pharmacy Battersea. The pharmacy opened as a totally private pharmacy and now operates alongside a CQC registered private health clinic with a multi-disciplinary team and two-way triage and referral in place. It operates 7-days a week with extended opening hours to match the Power Station shopping mall and increase access to healthcare whilst reducing pressures on the local health system.

The Director of Pharmacy and Superintendent Pharmacist is Daniella Fakhouri who leads the team including pharmacists Sammy Sutton and Bishoy Elwazan. LIPS Pharmacy Battersea is approaching the hybrid concept from the other direction. They have applied for an NHS contract to add to their private model to enable them to offer national and locally commissioned NHS services to eligible patients; this has not been a quick or easy process but hope to hear a successful outcome soon.

Picture2

The patient experience was uppermost in their mind when working with the architect, shop fitting agency and consultants. It certainly has the wow factor and the team ethos is very health and patient-centred.

The private services that they currently offer include dispensing private prescriptions which are either initiated following a consultation by their independent prescribing pharmacists within their scope of competences, clinicians in the clinic or from external private prescribers. Using their two clinical consultation rooms, they also offer flu vaccination, health checks, weight management, travel health, otoscopy, skin health, and common ailment services. In addition, they carry an extensive range of healthcare treatments, supplements and skin care.

The team are constantly exploring opportunities to expand their range of services. Daniella confirms that we should never underestimate the amount of work it takes to plan, develop competences and processes, and then implement and deliver a new service safely, one which provides an excellent patient experience. An example of a recent innovation has been linking their weight management service to the fertility service run in the clinic for patients with an identified clinical need. The pharmacy has already been a finalist in two categories at the 2024 Pharmacy Business Awards.

Digital health and technology underpin the operation with the Titan dispensary management system and a clinical management system, also used in the clinic, to facilitate appointment bookings, unified record keeping using consultation templates, prescription writing, tests, audit and communication with patients and other health professionals. They reach their audience, around 30% of whom are international travellers without immediate access to healthcare, and those looking for an accessible one-stop solution, through their website, Healthpoint screens, social media, building relationships and advocacy.

IMG 1587

This pharmacy-clinic model is the vision of Ibraheim El-Daly and Paul Culpan, both orthopaedic consultants and founders of London International Patient Services (LIPS). LIPS has been providing tertiary care services for nine years but wanted to develop an accessible end-to-end care solution for both UK and international patients. They are now based at the clinic adjacent to the pharmacy along with a growing clinical team, but also operate in hospitals across London while they build an ambulatory day case hospital in Battersea due to open in 2025.

Ibraheim sees other health professionals as partners, delivering services and an excellent patient experience by working collaboratively, not in silos. This includes Consultants, GPs, nurses, dentists, physiotherapists, dietitians and pharmacists. He describes pharmacists as a major asset – “a walking BNF with a personal touch” - and continues to learn so much from the LIPS Pharmacy team. This unique model, accessible in a shopping mall, is undoubtedly one that will continue to develop and be replicated.

IMG 1589

Written by Michael Holden FRPharmS FRSPH

Associate Director,

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less